Methods to screen for antibiotic agents and their use in treatment of opportunistic infections
The present invention provides novel targets in eukaryotic cells for antibiotic agents and methods for identification of antibiotic agents affecting such targets and the use of the identified antibiotic agents in treatment of opportunistic infections in eukaryotic hosts. The invention is based upon the identification of species specific 5′ hinge and 3′ hinge regions of U3 small nucleolar ribonucleic acid (snoRNA). The present invention discloses that the external transcribed spacer (ETS) of the ribosomal RNA precursor (pre-rRNA) comprises sequences that are complementary to the 5′ and 3′ hinge regions of U3 snoRNA. The invention further discloses that sequence substitutions of the 5′ hinge or 3′ hinge region of U3 snoRNA severely compromise or fully inhibit the cleavage events at sites 1 and 2 in rRNA processing necessary to form mature 18S rRNA which is a vital component of the small subunit of ribosomes of all eukaryotes.
1. A method of screening for an antibiotic agent comprising the steps of
(a) providing a mixture of a first recombinant RNA comprising 5′ and 3′ hinge regions of domain I of U3 snoRNA and a second recombinant RNA comprising pre-rRNA under conditions that allow binding of said first and second recombinant RNAs; and
(b) contacting said mixture with a candidate antibiotic agent under conditions which permit inhibition of said binding wherein inhibition of said binding is indicative of an antibiotic agent.
2. A method of screening for an antibiotic agent comprising the steps of
(a) providing in a living cell a mixture of a first recombinant RNA comprising 5′ and 3′ hinge regions of domain I of U3 snoRNA and a second recombinant RNA comprising pre-rRNA under conditions that allow processing of said second recombinant ribonucleic acid; and
(b) contacting said cell with a candidate antibiotic agent under conditions which permit inhibition of processing of said second recombinant RNA wherein said inhibition of processing is indicative of the antibiotic agent.
3. The method of claim 2 wherein the cell is an eukaryotic cell.
4. The method of claim 2 wherein the cell grows as a single cell.
5. The method of claim 2 wherein the cell is a yeast cell.
6. The method of claim 2 wherein the cell is a Xenopus oocyte.
7. A method of screening for an antibiotic agent comprising the steps of
(a) providing in a living cell a mixture of a first recombinant RNA comprising 3′ and 5′ hinge regions of domain I of U3 snoRNA and a second recombinant RNA comprising pre-rRNA under conditions that allow ribosome synthesis; and
(b) contacting said cell with a candidate antibiotic agent under conditions which permit inhibition of said ribosome synthesis wherein said inhibition of ribosome synthesis is indicative of the antibiotic agent.
8. The method of claim 7 wherein the cell is an eukaryotic cell.
9. The method of claim 7 wherein the cell grows as a single cell.
10. The method of claim 7 wherein the cell is a yeast cell.
11. The method of claim 7 wherein the cell is a Xenopus oocyte.
12. A method of screening for an antibiotic agent comprising the steps of
(a) providing in a living cell a mixture of a first recombinant RNA comprising 5′ and 3′ hinge regions of domain I of U3 snoRNA and a second recombinant RNA comprising pre-rRNA under conditions that allow protein synthesis; and
(b) contacting said cell with a candidate antibiotic agent under conditions which permit inhibition of protein synthesis wherein said inhibition of protein synthesis is indicative of the antibiotic agent.
13. The method of claim 12 wherein the cell is an eukaryotic cell.
14. The method of claim 12 wherein the cell grows as a single cell.
15. The method of claim 12 wherein the cell is a yeast cell.
16. A method of screening for an antibiotic agent comprising the steps of
(a) providing in a living cell a mixture of a first recombinant RNA comprising 5′ and 3′ hinge regions of domain I of U3 snoRNA and a second recombinant RNA comprising pre-rRNA under conditions that allow growth of said cell; and
(b) contacting said cell with a candidate antibiotic agent under conditions which permit inhibition of growth of said cell wherein said inhibition of inhibition of growth is indicative of the antibiotic agent.
17. The method of claim 16 wherein the cell, is an eukaryotic cell.
18. The method of claim 16 wherein the cell grows as a single cell.
19. The method of claim 16 wherein the cell is a yeast cell.
20. A method of screening for an antibiotic agent comprising the steps of
(a) providing in a living cell a mixture of a first recombinant RNA comprising 5′ and 3′ hinge regions of domain I of U3 snoRNA and a second recombinant RNA comprising pre-rRNA under conditions that allow division of said cell and thereby increase in the cell number; and
(b) contacting said cell with a candidate antibiotic agent under conditions which permit inhibition of said cell division wherein said inhibition of cell division is indicative of the antibiotic agent.
21. The method of claim 20 wherein the cell is an eukaryotic cell.
22. The method of claim 20 wherein the cell grows as a single cell.
23. The method of claim 20 wherein the cell is a yeast cell.
24. A method of screening for an antibiotic agent comprising the steps of
(a) providing in a living cell a mixture of a first recombinant RNA comprising 5′ and 3′ hinge regions of domain I of U3 snoRNA and a second recombinant RNA comprising pre-rRNA under conditions that allow said cell to live; and
(b) contacting said cell with a candidate antibiotic agent under conditions which permit inhibition of cell viability wherein said inhibition of cell viability is indicative of the antibiotic agent.
25. The method of claim 24 wherein the cell is an eukaryotic cell.
26. The method of claim 24 wherein the cell grows as a single cell.
27. The method of claim 24 wherein the cell is a yeast cell.